Clinical Drug Experience Knowledgebase

Pneumonia, Bacterial

Pulmonary Disease, Chronic Obstructive

Acute Lung Injury (Phase 2)

Alzheimer Disease (Phase 1)

Asthma (Phase 2)

Atrophy (Phase 2)

Attention Deficit Disorder with Hyperactivity (Phase 2)

Bacteremia (Phase 3)

Bacterial Infections (Phase 4)

Cellulitis (Phase 3)

Colitis (Phase 3)

Colitis, Ulcerative (Phase 3)

Communicable Diseases (Phase 3)

Constipation (Phase 2)

Critical Illness (Phase 2)

Crohn Disease (Phase 2)

Cystic Fibrosis (Phase 4)

Disease (Phase 2)

Fibromyalgia (Phase 2)

Fibrosis (Phase 4)

Gastroparesis (Phase 2)

Gram-Positive Bacterial Infections (Phase 4)

Healthcare-Associated Pneumonia (Phase 3)

Hepatitis (Phase 1)

Hepatitis A (Phase 1)

Hepatitis C (Phase 1)

Hyperkinesis (Phase 2)

Hypertension (Phase 1)

Hypotension (Phase 3)

Hypotension, Orthostatic (Phase 3)

Idiopathic Pulmonary Fibrosis (Phase 1)

Infections (Phase 3)

Inflammation (Phase 2)

Inflammatory Bowel Diseases (Phase 1)

Intestinal Diseases (Phase 1)

Kidney Diseases (Phase 4)

Kidney Failure, Chronic (Phase 4)

Liver Diseases (Phase 2)

Lung Diseases (Phase 3)

Lung Diseases, Obstructive (Phase 3)

Lung Injury (Phase 2)

Multiple System Atrophy (Phase 2)

Myofascial Pain Syndromes (Phase 2)

Parkinson Disease (Phase 2)

Pneumonia (Phase 3)

Pneumonia, Bacterial (Phase 3)

Pulmonary Disease, Chronic Obstructive (Phase 3)

Pulmonary Fibrosis (Phase 1)

Pulmonary Valve Insufficiency (Phase 2)

Pure Autonomic Failure (Phase 3)

Renal Insufficiency (Phase 2)

Renal Insufficiency, Chronic (Phase 4)

Respiratory Aspiration (Phase 3)

Respiratory Distress Syndrome (Phase 2)

Respiratory Insufficiency (Phase 2)

Shy-Drager Syndrome (Phase 2)

Skin Diseases, Infectious (Phase 3)

Staphylococcal Infections (Phase 3)

Staphylococcal Skin Infections (Phase 3)

Ulcer (Phase 3)

Wound Infection (Phase 2)